GKCC, LLC → Elicio Therapeutics, Inc. ELTX

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-07-15

DTC 1.11

1,875,723 shares short · +8.2% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $93K

Point72 Asset Mgmt

Other 13D/G Filings on Elicio Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2025-06-04	SCHEDULE	GKCC, LLC	48.00%	9,764,864	view →
2025-03-07	SCHEDULE	Chudnovsky Yekaterina	48.10%	9,657,539	view →

Other Filings by GKCC, LLC

Filed	Form	Issuer	Stake	Shares
2025-06-04	SCHEDULE	Elicio Therapeutics, Inc. ELTX	48.00%	9,764,864	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →